Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism

go back to reference Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the,guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the american society of echocardiography, american society of nuclear cardiology, heart rhythm society, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society for vascular medicine and biology, and society for vascular surgery. Circulation. 2002, 2007 (116): e418-e499. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the,guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the american society of echocardiography, american society of nuclear cardiology, heart rhythm society, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society for vascular medicine and biology, and society for vascular surgery. Circulation. 2002, 2007 (116): e418-e499.

go back to reference Gupta PK, Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ, Esterbrooks DJ, Hunter CB, Pipinos II, Johanning JM, Lynch TG, Forse RA, Mohiuddin SM, Mooss AN: Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011, 124: 381-387. 10.1161/CIRCULATIONAHA.110.015701.PubMed Gupta PK, Gupta H, Sundaram A, Kaushik M, Fang X, Miller WJ, Esterbrooks DJ, Hunter CB, Pipinos II, Johanning JM, Lynch TG, Forse RA, Mohiuddin SM, Mooss AN: Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011, 124: 381-387. 10.1161/CIRCULATIONAHA.110.015701.PubMed

go back to reference Unwin N, Whiting D, Guariguata L, Hennis A, Husseini A, Ji L, Kissimova-Skarbek K, Libman I, Mayer-Davis E, Motala A, Narayan V, Ramachandran A, Roglic G, Sham J, Wareham N, Zhang P: IDF diabetes atlas 2011. 2011, Brussels: International Diabetes Federation, 5 Unwin N, Whiting D, Guariguata L, Hennis A, Husseini A, Ji L, Kissimova-Skarbek K, Libman I, Mayer-Davis E, Motala A, Narayan V, Ramachandran A, Roglic G, Sham J, Wareham N, Zhang P: IDF diabetes atlas 2011. 2011, Brussels: International Diabetes Federation, 5

go back to reference Preis SR, Pencina MJ, Hwang SJ, D’Agostino RB, Savage PJ, Levy D, Fox CS: Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham heart study. Circulation. 2009, 120: 212-220. 10.1161/CIRCULATIONAHA.108.846519.PubMedCentralPubMed Preis SR, Pencina MJ, Hwang SJ, D’Agostino RB, Savage PJ, Levy D, Fox CS: Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham heart study. Circulation. 2009, 120: 212-220. 10.1161/CIRCULATIONAHA.108.846519.PubMedCentralPubMed

go back to reference Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999, 100: 1043-1049. 10.1161/01.CIR.100.10.1043.PubMed Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999, 100: 1043-1049. 10.1161/01.CIR.100.10.1043.PubMed

go back to reference Frassdorf J, De Hert S, Schlack W: Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth. 2009, 103: 89-98. 10.1093/bja/aep141.PubMed Frassdorf J, De Hert S, Schlack W: Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth. 2009, 103: 89-98. 10.1093/bja/aep141.PubMed

go back to reference De Hert SG, Preckel B, Hollmann MW, Schlack WS: Drugs mediating myocardial protection. Eur J Anaesthesiol. 2009, 26: 985-995. 10.1097/EJA.0b013e32832fad8b.PubMed De Hert SG, Preckel B, Hollmann MW, Schlack WS: Drugs mediating myocardial protection. Eur J Anaesthesiol. 2009, 26: 985-995. 10.1097/EJA.0b013e32832fad8b.PubMed

go back to reference Huhn R, Heinen A, Hollmann MW, Schlack W, Preckel B, Weber NC: Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr Metab Cardiovasc Dis. 2010, 20: 706-712. 10.1016/j.numecd.2009.06.010.PubMed Huhn R, Heinen A, Hollmann MW, Schlack W, Preckel B, Weber NC: Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr Metab Cardiovasc Dis. 2010, 20: 706-712. 10.1016/j.numecd.2009.06.010.PubMed

go back to reference Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002, 96: 183-188. 10.1097/00000542-200201000-00032.PubMed Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002, 96: 183-188. 10.1097/00000542-200201000-00032.PubMed

go back to reference Lucchinetti E, Wang L, Ko KW, Troxler H, Hersberger M, Zhang L, Omar MA, Lopaschuk GD, Clanachan AS, Zaugg M: Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia-reperfusion injury in sevoflurane- but not propofol-treated hearts. Br J Anaesth. 2011, 106: 792-800. 10.1093/bja/aer065.PubMed Lucchinetti E, Wang L, Ko KW, Troxler H, Hersberger M, Zhang L, Omar MA, Lopaschuk GD, Clanachan AS, Zaugg M: Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia-reperfusion injury in sevoflurane- but not propofol-treated hearts. Br J Anaesth. 2011, 106: 792-800. 10.1093/bja/aer065.PubMed

go back to reference Lucchinetti E, Hofer C, Bestmann L, Hersberger M, Feng J, Zhu M, Furrer L, Schaub MC, Tavakoli R, Genoni M, Zollinger A, Zaugg M: Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology. 2007, 106: 444-457. 10.1097/00000542-200703000-00008.PubMed Lucchinetti E, Hofer C, Bestmann L, Hersberger M, Feng J, Zhu M, Furrer L, Schaub MC, Tavakoli R, Genoni M, Zollinger A, Zaugg M: Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology. 2007, 106: 444-457. 10.1097/00000542-200703000-00008.PubMed

go back to reference Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, Hersberger M, Omar MA, Posse de Chaves EI, Lopaschuk GD, Clanachan AS, Zaugg M: Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology. 2010, 113: 541-551.PubMed Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, Hersberger M, Omar MA, Posse de Chaves EI, Lopaschuk GD, Clanachan AS, Zaugg M: Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology. 2010, 113: 541-551.PubMed

go back to reference Winterstein H: Ueber die Sauerstoffatmung des isolierten Saeugetierherzens. Z Allg Physiol. 1904, 4: 339-359. Winterstein H: Ueber die Sauerstoffatmung des isolierten Saeugetierherzens. Z Allg Physiol. 1904, 4: 339-359.

go back to reference Stanley WC, Lopaschuk GD, McCormack JG: Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 1997, 34: 25-33. 10.1016/S0008-6363(97)00047-3.PubMed Stanley WC, Lopaschuk GD, McCormack JG: Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res. 1997, 34: 25-33. 10.1016/S0008-6363(97)00047-3.PubMed

go back to reference Carley AN, Severson DL: Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta. 2005, 1734: 112-126. 10.1016/j.bbalip.2005.03.005.PubMed Carley AN, Severson DL: Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta. 2005, 1734: 112-126. 10.1016/j.bbalip.2005.03.005.PubMed

go back to reference Neely JR, Rovetto MJ, Oram JF: Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972, 15: 289-329. 10.1016/0033-0620(72)90029-1.PubMed Neely JR, Rovetto MJ, Oram JF: Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972, 15: 289-329. 10.1016/0033-0620(72)90029-1.PubMed

go back to reference Taegtmeyer H: Glycogen in the heart–an expanded view. J Mol Cell Cardiol. 2004, 37: 7-10. 10.1016/j.yjmcc.2004.05.001.PubMed Taegtmeyer H: Glycogen in the heart–an expanded view. J Mol Cell Cardiol. 2004, 37: 7-10. 10.1016/j.yjmcc.2004.05.001.PubMed

go back to reference Shepherd PR, Kahn BB: Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999, 341: 248-257. 10.1056/NEJM199907223410406.PubMed Shepherd PR, Kahn BB: Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. N Engl J Med. 1999, 341: 248-257. 10.1056/NEJM199907223410406.PubMed

go back to reference Coort SL, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ: Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem. 2007, 299: 5-18. 10.1007/s11010-005-9030-5.PubMed Coort SL, Bonen A, van der Vusse GJ, Glatz JF, Luiken JJ: Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters. Mol Cell Biochem. 2007, 299: 5-18. 10.1007/s11010-005-9030-5.PubMed

go back to reference Lewin TM, Coleman RA: Regulation of myocardial triacylglycerol synthesis and metabolism. Biochim Biophys Acta. 2003, 1634: 63-75. 10.1016/j.bbalip.2003.09.006.PubMed Lewin TM, Coleman RA: Regulation of myocardial triacylglycerol synthesis and metabolism. Biochim Biophys Acta. 2003, 1634: 63-75. 10.1016/j.bbalip.2003.09.006.PubMed

go back to reference Kerner J, Hoppel C: Fatty acid import into mitochondria. Biochim Biophys Acta. 2000, 1486: 1-17. 10.1016/S1388-1981(00)00044-5.PubMed Kerner J, Hoppel C: Fatty acid import into mitochondria. Biochim Biophys Acta. 2000, 1486: 1-17. 10.1016/S1388-1981(00)00044-5.PubMed

go back to reference Stanley WC, Recchia FA, Lopaschuk GD: Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005, 85: 1093-1129. 10.1152/physrev.00006.2004.PubMed Stanley WC, Recchia FA, Lopaschuk GD: Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005, 85: 1093-1129. 10.1152/physrev.00006.2004.PubMed

go back to reference Saddik M, Lopaschuk GD: Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem. 1991, 266: 8162-8170.PubMed Saddik M, Lopaschuk GD: Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem. 1991, 266: 8162-8170.PubMed

go back to reference Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC: Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010, 90: 207-258. 10.1152/physrev.00015.2009.PubMed Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC: Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010, 90: 207-258. 10.1152/physrev.00015.2009.PubMed

go back to reference van den Brom CE, Bosmans JW, Vlasblom R, Handoko ML, Huisman MC, Lubberink M, Molthoff CF, Lammertsma AA, Ouwens DM, Diamant M, Boer C: Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle. Cardiovasc Diabetol. 2010, 9: 25-10.1186/1475-2840-9-25.PubMedCentralPubMed van den Brom CE, Bosmans JW, Vlasblom R, Handoko ML, Huisman MC, Lubberink M, Molthoff CF, Lammertsma AA, Ouwens DM, Diamant M, Boer C: Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle. Cardiovasc Diabetol. 2010, 9: 25-10.1186/1475-2840-9-25.PubMedCentralPubMed

go back to reference van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, Van der Velden J, Boer C, Ouwens DM, Diamant M: Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol. 2009, 8: 39-10.1186/1475-2840-8-39.PubMedCentralPubMed van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, Van der Velden J, Boer C, Ouwens DM, Diamant M: Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovasc Diabetol. 2009, 8: 39-10.1186/1475-2840-8-39.PubMedCentralPubMed

go back to reference Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD: Targeting fatty acid and carbohydrate oxidation–a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta. 1813, 2011: 1333-1350. Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD: Targeting fatty acid and carbohydrate oxidation–a novel therapeutic intervention in the ischemic and failing heart. Biochim Biophys Acta. 1813, 2011: 1333-1350.

go back to reference Opie LH: The heart; Physiology and Metabolism. 1991, New York: Raven Press Opie LH: The heart; Physiology and Metabolism. 1991, New York: Raven Press

go back to reference Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974, 34: 29-34. 10.1016/0002-9149(74)90089-7.PubMed Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974, 34: 29-34. 10.1016/0002-9149(74)90089-7.PubMed

go back to reference Rennert G, Saltz-Rennert H, Wanderman K, Weitzman S: Size of acute myocardial infarcts in patients with diabetes mellitus. Am J Cardiol. 1985, 55: 1629-1630. 10.1016/0002-9149(85)90988-9.PubMed Rennert G, Saltz-Rennert H, Wanderman K, Weitzman S: Size of acute myocardial infarcts in patients with diabetes mellitus. Am J Cardiol. 1985, 55: 1629-1630. 10.1016/0002-9149(85)90988-9.PubMed

go back to reference How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS: Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes. 2006, 55: 466-473. 10.2337/diabetes.55.02.06.db05-1164.PubMed How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS: Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes. 2006, 55: 466-473. 10.2337/diabetes.55.02.06.db05-1164.PubMed

go back to reference Paulson DJ: The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res. 1997, 34: 104-112. 10.1016/S0008-6363(97)00018-7.PubMed Paulson DJ: The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res. 1997, 34: 104-112. 10.1016/S0008-6363(97)00018-7.PubMed

go back to reference van den Brom CE, Bulte CS, Kloeze BM, Loer SA, Boer C, Bouwman RA: High fat diet-induced glucose intolerance impairs myocardial function, but not myocardial perfusion during hyperaemia: a pilot study. Cardiovasc Diabetol. 2012, 11: 74-10.1186/1475-2840-11-74.PubMedCentralPubMed van den Brom CE, Bulte CS, Kloeze BM, Loer SA, Boer C, Bouwman RA: High fat diet-induced glucose intolerance impairs myocardial function, but not myocardial perfusion during hyperaemia: a pilot study. Cardiovasc Diabetol. 2012, 11: 74-10.1186/1475-2840-11-74.PubMedCentralPubMed

go back to reference Ivanova M, Janega P, Matejikova J, Simoncikova P, Pancza D, Ravingerova T, Barancik M: Activation of Akt kinase accompanies increased cardiac resistance to ischemia/reperfusion in rats after short-term feeding with lard-based high-fat diet and increased sucrose intake. Nutr Res. 2011, 31: 631-643. 10.1016/j.nutres.2011.08.005.PubMed Ivanova M, Janega P, Matejikova J, Simoncikova P, Pancza D, Ravingerova T, Barancik M: Activation of Akt kinase accompanies increased cardiac resistance to ischemia/reperfusion in rats after short-term feeding with lard-based high-fat diet and increased sucrose intake. Nutr Res. 2011, 31: 631-643. 10.1016/j.nutres.2011.08.005.PubMed

go back to reference Rennison JH, McElfresh TA, Chen X, Anand VR, Hoit BD, Hoppel CL, Chandler MP: Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure. J Mol Cell Cardiol. 2009, 46: 883-890. 10.1016/j.yjmcc.2009.02.019.PubMedCentralPubMed Rennison JH, McElfresh TA, Chen X, Anand VR, Hoit BD, Hoppel CL, Chandler MP: Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure. J Mol Cell Cardiol. 2009, 46: 883-890. 10.1016/j.yjmcc.2009.02.019.PubMedCentralPubMed

go back to reference Jordan JE, Simandle SA, Tulbert CD, Busija DW, Miller AW: Fructose-fed rats are protected against ischemia/reperfusion injury. J Pharmacol Exp Ther. 2003, 307: 1007-1011. 10.1124/jpet.103.055970.PubMed Jordan JE, Simandle SA, Tulbert CD, Busija DW, Miller AW: Fructose-fed rats are protected against ischemia/reperfusion injury. J Pharmacol Exp Ther. 2003, 307: 1007-1011. 10.1124/jpet.103.055970.PubMed

go back to reference Morgan EE, Rennison JH, Young ME, McElfresh TA, Kung TA, Tserng KY, Hoit BD, Stanley WC, Chandler MP: Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure. Am J Physiol Heart Circ Physiol. 2006, 290: H1899-H1904. 10.1152/ajpheart.01014.2005.PubMed Morgan EE, Rennison JH, Young ME, McElfresh TA, Kung TA, Tserng KY, Hoit BD, Stanley WC, Chandler MP: Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure. Am J Physiol Heart Circ Physiol. 2006, 290: H1899-H1904. 10.1152/ajpheart.01014.2005.PubMed

go back to reference Rennison JH, McElfresh TA, Okere IC, Vazquez EJ, Patel HV, Foster AB, Patel KK, Chen Q, Hoit BD, Tserng KY, Hassan MO, Hoppel CL, Chandler MP: High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol. 2007, 292: H1498-H1506.PubMed Rennison JH, McElfresh TA, Okere IC, Vazquez EJ, Patel HV, Foster AB, Patel KK, Chen Q, Hoit BD, Tserng KY, Hassan MO, Hoppel CL, Chandler MP: High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol. 2007, 292: H1498-H1506.PubMed

go back to reference Mozaffari MS, Patel C, Ballas C, Schaffer SW: Effects of excess salt and fat intake on myocardial function and infarct size in rat. Life Sci. 2006, 78: 1808-1813. 10.1016/j.lfs.2005.08.014.PubMed Mozaffari MS, Patel C, Ballas C, Schaffer SW: Effects of excess salt and fat intake on myocardial function and infarct size in rat. Life Sci. 2006, 78: 1808-1813. 10.1016/j.lfs.2005.08.014.PubMed

go back to reference Berthiaume JM, Young ME, Chen X, McElfresh TA, Yu X, Chandler MP: Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding. J Mol Cell Cardiol. 2012, 53: 125-133. 10.1016/j.yjmcc.2012.04.005.PubMedCentralPubMed Berthiaume JM, Young ME, Chen X, McElfresh TA, Yu X, Chandler MP: Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding. J Mol Cell Cardiol. 2012, 53: 125-133. 10.1016/j.yjmcc.2012.04.005.PubMedCentralPubMed

go back to reference Song T, Lv LY, Xu J, Tian ZY, Cui WY, Wang QS, Qu G, Shi XM: Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway. Exp Biol Med (Maywood). 2011, 236: 1427-1436. 10.1258/ebm.2011.011165. Song T, Lv LY, Xu J, Tian ZY, Cui WY, Wang QS, Qu G, Shi XM: Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway. Exp Biol Med (Maywood). 2011, 236: 1427-1436. 10.1258/ebm.2011.011165.

go back to reference Morel S, Berthonneche C, Tanguy S, Toufektsian MC, Perret P, Ghezzi C, de Leiris J, Boucher F: Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats. Mol Cell Biochem. 2005, 272: 9-17. 10.1007/s11010-005-4778-1.PubMed Morel S, Berthonneche C, Tanguy S, Toufektsian MC, Perret P, Ghezzi C, de Leiris J, Boucher F: Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats. Mol Cell Biochem. 2005, 272: 9-17. 10.1007/s11010-005-4778-1.PubMed

go back to reference Maddaford TG, Russell JC, Pierce GN: Postischemic cardiac performance in the insulin-resistant JCR:LA-cp rat. Am J Physiol. 1997, 273: H1187-H1192.PubMed Maddaford TG, Russell JC, Pierce GN: Postischemic cardiac performance in the insulin-resistant JCR:LA-cp rat. Am J Physiol. 1997, 273: H1187-H1192.PubMed

go back to reference Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K: Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. Diabetes. 2002, 51: 1110-1117. 10.2337/diabetes.51.4.1110.PubMed Sidell RJ, Cole MA, Draper NJ, Desrois M, Buckingham RE, Clarke K: Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart. Diabetes. 2002, 51: 1110-1117. 10.2337/diabetes.51.4.1110.PubMed

go back to reference Mozaffari MS, Schaffer SW: Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome. Obesity (Silver Spring). 2008, 16: 2253-2258. 10.1038/oby.2008.356. Mozaffari MS, Schaffer SW: Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome. Obesity (Silver Spring). 2008, 16: 2253-2258. 10.1038/oby.2008.356.

go back to reference Thakker GD, Frangogiannis NG, Zymek PT, Sharma S, Raya JL, Barger PM, Taegtmeyer H, Entman ML, Ballantyne CM: Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity. Obesity (Silver Spring). 2008, 16: 2593-2600. 10.1038/oby.2008.414. Thakker GD, Frangogiannis NG, Zymek PT, Sharma S, Raya JL, Barger PM, Taegtmeyer H, Entman ML, Ballantyne CM: Increased myocardial susceptibility to repetitive ischemia with high-fat diet-induced obesity. Obesity (Silver Spring). 2008, 16: 2593-2600. 10.1038/oby.2008.414.

go back to reference Aasum E, Hafstad AD, Severson DL, Larsen TS: Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes. 2003, 52: 434-441.PubMed Aasum E, Hafstad AD, Severson DL, Larsen TS: Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes. 2003, 52: 434-441.PubMed

go back to reference Yue TL, Bao W, Gu JL, Cui J, Tao L, Ma XL, Ohlstein EH, Jucker BM: Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury. Diabetes. 2005, 54: 554-562.PubMed Yue TL, Bao W, Gu JL, Cui J, Tao L, Ma XL, Ohlstein EH, Jucker BM: Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury. Diabetes. 2005, 54: 554-562.PubMed

go back to reference Wang P, Chatham JC: Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab. 2004, 286: E725-E736. 10.1152/ajpendo.00295.2003.PubMed Wang P, Chatham JC: Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab. 2004, 286: E725-E736. 10.1152/ajpendo.00295.2003.PubMed

go back to reference Hoshida S, Yamashita N, Otsu K, Kuzuya T, Hori M: Cholesterol feeding exacerbates myocardial injury in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol. 2000, 278: H256-H262.PubMed Hoshida S, Yamashita N, Otsu K, Kuzuya T, Hori M: Cholesterol feeding exacerbates myocardial injury in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol. 2000, 278: H256-H262.PubMed

go back to reference Higuchi M, Miyagi K, Nakasone J, Sakanashi M: Role of high glycogen in underperfused diabetic rat hearts with added norepinephrine. J Cardiovasc Pharmacol. 1995, 26: 899-907. 10.1097/00005344-199512000-00008.PubMed Higuchi M, Miyagi K, Nakasone J, Sakanashi M: Role of high glycogen in underperfused diabetic rat hearts with added norepinephrine. J Cardiovasc Pharmacol. 1995, 26: 899-907. 10.1097/00005344-199512000-00008.PubMed

go back to reference Cross HR, Opie LH, Radda GK, Clarke K: Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res. 1996, 78: 482-491. 10.1161/01.RES.78.3.482.PubMed Cross HR, Opie LH, Radda GK, Clarke K: Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res. 1996, 78: 482-491. 10.1161/01.RES.78.3.482.PubMed

go back to reference Feuvray D, Lopaschuk GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997, 34: 113-120. 10.1016/S0008-6363(97)00037-0.PubMed Feuvray D, Lopaschuk GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res. 1997, 34: 113-120. 10.1016/S0008-6363(97)00037-0.PubMed

go back to reference Yao YT, Fang NX, Shi CX, Li LH: Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Chin Med J (Engl). 2010, 123: 1320-1328. Yao YT, Fang NX, Shi CX, Li LH: Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Chin Med J (Engl). 2010, 123: 1320-1328.

go back to reference Bouwman RA, Vreden MJ, Hamdani N, Wassenaar LE, Smeding L, Loer SA, Stienen GJ, Lamberts RR: Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts. Eur J Pharmacol. 2010, 647: 132-138. 10.1016/j.ejphar.2010.08.014.PubMed Bouwman RA, Vreden MJ, Hamdani N, Wassenaar LE, Smeding L, Loer SA, Stienen GJ, Lamberts RR: Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts. Eur J Pharmacol. 2010, 647: 132-138. 10.1016/j.ejphar.2010.08.014.PubMed

go back to reference Tosaka S, Tosaka R, Matsumoto S, Maekawa T, Cho S, Sumikawa K: Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts. J Cardiovasc Pharmacol Ther. 2011, 16: 72-78. 10.1177/1074248410380208.PubMed Tosaka S, Tosaka R, Matsumoto S, Maekawa T, Cho S, Sumikawa K: Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts. J Cardiovasc Pharmacol Ther. 2011, 16: 72-78. 10.1177/1074248410380208.PubMed

go back to reference Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W: The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg. 2005, 101: 1252-1260. 10.1213/01.ANE.0000181336.96511.32.PubMed Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W: The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg. 2005, 101: 1252-1260. 10.1213/01.ANE.0000181336.96511.32.PubMed

go back to reference Lang XE, Wang X, Jin JH: Mechanisms of cardioprotection by isoflurane against I/R injury. Front Biosci. 2013, 18: 387-393. 10.2741/4109. Lang XE, Wang X, Jin JH: Mechanisms of cardioprotection by isoflurane against I/R injury. Front Biosci. 2013, 18: 387-393. 10.2741/4109.

go back to reference Yao Y, Li L, Li L, Gao C, Shi C: Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion. Biol Pharm Bull. 2009, 32: 1854-1861. 10.1248/bpb.32.1854.PubMed Yao Y, Li L, Li L, Gao C, Shi C: Sevoflurane postconditioning protects chronically-infarcted rat hearts against ischemia-reperfusion injury by activation of pro-survival kinases and inhibition of mitochondrial permeability transition pore opening upon reperfusion. Biol Pharm Bull. 2009, 32: 1854-1861. 10.1248/bpb.32.1854.PubMed

go back to reference Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ: Volatile anesthetic-induced cardiac preconditioning. J Anesth. 2007, 21: 212-219. 10.1007/s00540-006-0486-6.PubMed Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ: Volatile anesthetic-induced cardiac preconditioning. J Anesth. 2007, 21: 212-219. 10.1007/s00540-006-0486-6.PubMed

go back to reference Lattermann R, Schricker T, Wachter U, Georgieff M, Goertz A: Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery. Anesth Analg. 2001, 93: 121-127.PubMed Lattermann R, Schricker T, Wachter U, Georgieff M, Goertz A: Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery. Anesth Analg. 2001, 93: 121-127.PubMed

go back to reference Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, Boer C: Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection. Anesthesiology. 2004, 100: 506-514. 10.1097/00000542-200403000-00008.PubMed Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, Boer C: Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection. Anesthesiology. 2004, 100: 506-514. 10.1097/00000542-200403000-00008.PubMed

go back to reference Costa AD, Quinlan CL, Andrukhiv A, West IC, Jaburek M, Garlid KD: The direct physiological effects of mitoK(ATP) opening on heart mitochondria. Am J Physiol Heart Circ Physiol. 2006, 290: H406-H415.PubMed Costa AD, Quinlan CL, Andrukhiv A, West IC, Jaburek M, Garlid KD: The direct physiological effects of mitoK(ATP) opening on heart mitochondria. Am J Physiol Heart Circ Physiol. 2006, 290: H406-H415.PubMed

go back to reference Flores JE, McFarland LM, Vanderbilt A, Ogasawara AK, Williams SP: The effects of anesthetic agent and carrier gas on blood glucose and tissue uptake in mice undergoing dynamic FDG-PET imaging: sevoflurane and isoflurane compared in air and in oxygen. Mol Imaging Biol. 2008, 10: 192-200. 10.1007/s11307-008-0137-4.PubMed Flores JE, McFarland LM, Vanderbilt A, Ogasawara AK, Williams SP: The effects of anesthetic agent and carrier gas on blood glucose and tissue uptake in mice undergoing dynamic FDG-PET imaging: sevoflurane and isoflurane compared in air and in oxygen. Mol Imaging Biol. 2008, 10: 192-200. 10.1007/s11307-008-0137-4.PubMed

go back to reference Toyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, Seidel J, Green MV, Innis RB: Evaluation of anesthesia effects on [18 F]FDG uptake in mouse brain and heart using small animal PET. Nucl Med Biol. 2004, 31: 251-256. 10.1016/S0969-8051(03)00124-0.PubMed Toyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, Seidel J, Green MV, Innis RB: Evaluation of anesthesia effects on [18 F]FDG uptake in mouse brain and heart using small animal PET. Nucl Med Biol. 2004, 31: 251-256. 10.1016/S0969-8051(03)00124-0.PubMed

go back to reference Kudoh A, Katagai H, Takazawa T: Sevoflurane increases glucose transport in skeletal muscle cells. Anesth Analg. 2002, 95: 123-128. 10.1097/00000539-200207000-00022. tablePubMed Kudoh A, Katagai H, Takazawa T: Sevoflurane increases glucose transport in skeletal muscle cells. Anesth Analg. 2002, 95: 123-128. 10.1097/00000539-200207000-00022. tablePubMed

go back to reference Ewart RB, Rusy BF, Bradford MW: Effects of enflurane on release of insulin by pancreatic islets in vitro. Anesth Analg. 1981, 60: 878-884.PubMed Ewart RB, Rusy BF, Bradford MW: Effects of enflurane on release of insulin by pancreatic islets in vitro. Anesth Analg. 1981, 60: 878-884.PubMed

go back to reference Tanaka K, Kawano T, Tsutsumi YM, Kinoshita M, Kakuta N, Hirose K, Kimura M, Oshita S: Differential effects of propofol and isoflurane on glucose utilization and insulin secretion. Life Sci. 2011, 88: 96-103. 10.1016/j.lfs.2010.10.032.PubMed Tanaka K, Kawano T, Tsutsumi YM, Kinoshita M, Kakuta N, Hirose K, Kimura M, Oshita S: Differential effects of propofol and isoflurane on glucose utilization and insulin secretion. Life Sci. 2011, 88: 96-103. 10.1016/j.lfs.2010.10.032.PubMed

go back to reference Zuurbier CJ, Keijzers PJ, Koeman A, Van Wezel HB, Hollmann MW: Anesthesia’s effects on plasma glucose and insulin and cardiac hexokinase at similar hemodynamics and without major surgical stress in fed rats. Anesth Analg. 2008, 106: 135-142. 10.1213/01.ane.0000297299.91527.74.PubMed Zuurbier CJ, Keijzers PJ, Koeman A, Van Wezel HB, Hollmann MW: Anesthesia’s effects on plasma glucose and insulin and cardiac hexokinase at similar hemodynamics and without major surgical stress in fed rats. Anesth Analg. 2008, 106: 135-142. 10.1213/01.ane.0000297299.91527.74.PubMed

go back to reference Kitamura T, Ogawa M, Kawamura G, Sato K, Yamada Y: The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats. Anesth Analg. 2009, 109: 1479-1485. 10.1213/ANE.0b013e3181b8554a.PubMed Kitamura T, Ogawa M, Kawamura G, Sato K, Yamada Y: The effects of sevoflurane and propofol on glucose metabolism under aerobic conditions in fed rats. Anesth Analg. 2009, 109: 1479-1485. 10.1213/ANE.0b013e3181b8554a.PubMed

go back to reference Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM: Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005, 111: 3078-3086. 10.1161/CIRCULATIONAHA.104.517839.PubMed Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM: Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005, 111: 3078-3086. 10.1161/CIRCULATIONAHA.104.517839.PubMed

go back to reference Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW: Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R920-R926.PubMed Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW: Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R920-R926.PubMed

go back to reference Wagner C, Kloeting I, Strasser RH, Weinbrenner C: Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol. 2008, 52: 430-437. 10.1097/FJC.0b013e31818c12a7.PubMed Wagner C, Kloeting I, Strasser RH, Weinbrenner C: Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol. 2008, 52: 430-437. 10.1097/FJC.0b013e31818c12a7.PubMed

go back to reference Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyorgyi R, Nagy I, Koltai M, Dux L: Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol. 1997, 29: 3321-3333. 10.1006/jmcc.1997.0557.PubMed Ferdinandy P, Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyorgyi R, Nagy I, Koltai M, Dux L: Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol. 1997, 29: 3321-3333. 10.1006/jmcc.1997.0557.PubMed

go back to reference Kocic I, Konstanski Z, Kaminski M, Dworakowska D, Dworakowski R: Experimental hyperlipidemia prevents the protective effect of ischemic preconditioning on the contractility and responsiveness to phenylephrine of rat-isolated stunned papillary muscle. Gen Pharmacol. 1999, 33: 213-219. 10.1016/S0306-3623(99)00017-8.PubMed Kocic I, Konstanski Z, Kaminski M, Dworakowska D, Dworakowski R: Experimental hyperlipidemia prevents the protective effect of ischemic preconditioning on the contractility and responsiveness to phenylephrine of rat-isolated stunned papillary muscle. Gen Pharmacol. 1999, 33: 213-219. 10.1016/S0306-3623(99)00017-8.PubMed

go back to reference Zhang FJ, Ma LL, Wang WN, Qian LB, Yang MJ, Yu J, Chen G, Yu LN, Yan M: Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling. Shock. 2012, 37: 485-491. 10.1097/SHK.0b013e318249b7b6.PubMed Zhang FJ, Ma LL, Wang WN, Qian LB, Yang MJ, Yu J, Chen G, Yu LN, Yan M: Hypercholesterolemia abrogates sevoflurane-induced delayed preconditioning against myocardial infarct in rats by alteration of nitric oxide synthase signaling. Shock. 2012, 37: 485-491. 10.1097/SHK.0b013e318249b7b6.PubMed

go back to reference Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation. 1999, 99: 2626-2632. 10.1161/01.CIR.99.20.2626.PubMed Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation. 1999, 99: 2626-2632. 10.1161/01.CIR.99.20.2626.PubMed

go back to reference Weber NC, Goletz C, Huhn R, Grueber Y, Preckel B, Schlack W, Ebel D: Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases. Eur J Pharmacol. 2008, 592: 48-54. 10.1016/j.ejphar.2008.07.010.PubMed Weber NC, Goletz C, Huhn R, Grueber Y, Preckel B, Schlack W, Ebel D: Blockade of anaesthetic-induced preconditioning in the hyperglycaemic myocardium: the regulation of different mitogen-activated protein kinases. Eur J Pharmacol. 2008, 592: 48-54. 10.1016/j.ejphar.2008.07.010.PubMed

go back to reference Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR: N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology. 2003, 98: 1384-1390. 10.1097/00000542-200306000-00013.PubMed Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR: N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology. 2003, 98: 1384-1390. 10.1097/00000542-200306000-00013.PubMed

go back to reference Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B: Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth. 2008, 100: 465-471. 10.1093/bja/aen022.PubMed Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B: Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth. 2008, 100: 465-471. 10.1093/bja/aen022.PubMed

go back to reference Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC: Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol. 2000, 278: H1218-H1224.PubMed Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC: Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol. 2000, 278: H1218-H1224.PubMed

go back to reference Tanaka K, Kehl F, Gu W, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol. 2002, 282: H2018-H2023.PubMed Tanaka K, Kehl F, Gu W, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol. 2002, 282: H2018-H2023.PubMed

go back to reference Raphael J, Gozal Y, Navot N, Zuo Z: Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol. 2010, 55: 348-357. 10.1097/FJC.0b013e3181d26583.PubMed Raphael J, Gozal Y, Navot N, Zuo Z: Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol. 2010, 55: 348-357. 10.1097/FJC.0b013e3181d26583.PubMed

go back to reference Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A: Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia. 2004, 47: 1716-1721. 10.1007/s00125-004-1514-4.PubMed Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyvbjerg A: Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia. 2004, 47: 1716-1721. 10.1007/s00125-004-1514-4.PubMed

go back to reference Miki T, Itoh T, Sunaga D, Miura T: Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol. 2012, 11: 67-10.1186/1475-2840-11-67.PubMedCentralPubMed Miki T, Itoh T, Sunaga D, Miura T: Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol. 2012, 11: 67-10.1186/1475-2840-11-67.PubMedCentralPubMed

go back to reference Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM: Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005, 54: 2360-2364. 10.2337/diabetes.54.8.2360.PubMed Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM: Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005, 54: 2360-2364. 10.2337/diabetes.54.8.2360.PubMed

go back to reference Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH: Diabetes blockade of sevoflurane postconditioning is Not restored by insulin in the Rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology. 2011, 114: 1364-1372. 10.1097/ALN.0b013e31820efafd.PubMed Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH: Diabetes blockade of sevoflurane postconditioning is Not restored by insulin in the Rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology. 2011, 114: 1364-1372. 10.1097/ALN.0b013e31820efafd.PubMed

go back to reference Paiva MA, Rutter-Locher Z, Goncalves LM, Providencia LA, Davidson SM, Yellon DM, Mocanu MM: Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol. 2011, 300: H2123-H2134. 10.1152/ajpheart.00707.2010.PubMedCentralPubMed Paiva MA, Rutter-Locher Z, Goncalves LM, Providencia LA, Davidson SM, Yellon DM, Mocanu MM: Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am J Physiol Heart Circ Physiol. 2011, 300: H2123-H2134. 10.1152/ajpheart.00707.2010.PubMedCentralPubMed

go back to reference Penna C, Mancardi D, Gattullo D, Pagliaro P: Myocardial protection from ischemic preconditioning is not blocked by sub-chronic inhibition of carnitine palmitoyltransferase I. Life Sci. 2005, 77: 2004-2017. 10.1016/j.lfs.2005.03.017.PubMed Penna C, Mancardi D, Gattullo D, Pagliaro P: Myocardial protection from ischemic preconditioning is not blocked by sub-chronic inhibition of carnitine palmitoyltransferase I. Life Sci. 2005, 77: 2004-2017. 10.1016/j.lfs.2005.03.017.PubMed

go back to reference Lopaschuk GD, Spafford MA, Davies NJ, Wall SR: Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res. 1990, 66: 546-553. 10.1161/01.RES.66.2.546.PubMed Lopaschuk GD, Spafford MA, Davies NJ, Wall SR: Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res. 1990, 66: 546-553. 10.1161/01.RES.66.2.546.PubMed

go back to reference Lopaschuk GD, Saddik M: The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Mol Cell Biochem. 1992, 116: 111-116. 10.1007/BF01270577.PubMed Lopaschuk GD, Saddik M: The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Mol Cell Biochem. 1992, 116: 111-116. 10.1007/BF01270577.PubMed

go back to reference Kennedy JA, Kiosoglous AJ, Murphy GA, Pelle MA, Horowitz JD: Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. J Cardiovasc Pharmacol. 2000, 36: 794-801. 10.1097/00005344-200012000-00016.PubMed Kennedy JA, Kiosoglous AJ, Murphy GA, Pelle MA, Horowitz JD: Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. J Cardiovasc Pharmacol. 2000, 36: 794-801. 10.1097/00005344-200012000-00016.PubMed

go back to reference Molaparast-Saless F, Liedtke AJ, Nellis SH: Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium. J Mol Cell Cardiol. 1987, 19: 509-520. 10.1016/S0022-2828(87)80402-9.PubMed Molaparast-Saless F, Liedtke AJ, Nellis SH: Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium. J Mol Cell Cardiol. 1987, 19: 509-520. 10.1016/S0022-2828(87)80402-9.PubMed

go back to reference Kara AF, Demiryurek S, Celik A, Tarakcioglu M, Demiryurek AT: Effects of trimetazidine on myocardial preconditioning in anesthetized rats. Eur J Pharmacol. 2004, 503: 135-145. 10.1016/j.ejphar.2004.09.037.PubMed Kara AF, Demiryurek S, Celik A, Tarakcioglu M, Demiryurek AT: Effects of trimetazidine on myocardial preconditioning in anesthetized rats. Eur J Pharmacol. 2004, 503: 135-145. 10.1016/j.ejphar.2004.09.037.PubMed

go back to reference Mouquet F, Rousseau D, Domergue-Dupont V, Grynberg A, Liao R: Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat. Fundam Clin Pharmacol. 2010, 24: 469-476.PubMed Mouquet F, Rousseau D, Domergue-Dupont V, Grynberg A, Liao R: Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat. Fundam Clin Pharmacol. 2010, 24: 469-476.PubMed

go back to reference McCormack JG, Barr RL, Wolff AA, Lopaschuk GD: Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation. 1996, 93: 135-142. 10.1161/01.CIR.93.1.135.PubMed McCormack JG, Barr RL, Wolff AA, Lopaschuk GD: Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation. 1996, 93: 135-142. 10.1161/01.CIR.93.1.135.PubMed

go back to reference Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC: A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. J Pharmacol Exp Ther. 2007, 321: 213-220. 10.1124/jpet.106.115519.PubMed Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC: A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. J Pharmacol Exp Ther. 2007, 321: 213-220. 10.1124/jpet.106.115519.PubMed

go back to reference McVeigh JJ, Lopaschuk GD: Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol. 1990, 259: H1079-H1085.PubMed McVeigh JJ, Lopaschuk GD: Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol. 1990, 259: H1079-H1085.PubMed

go back to reference Lopaschuk GD, McNeil GF, McVeigh JJ: Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir. Mol Cell Biochem. 1989, 88: 175-179.PubMed Lopaschuk GD, McNeil GF, McVeigh JJ: Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir. Mol Cell Biochem. 1989, 88: 175-179.PubMed

go back to reference Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, Isea JE, Romero G: Metabolic modulation of acute myocardial infarction. The ECLA (estudios cardiologicos latinoamerica) collaborative group. Circulation. 1998, 98: 2227-2234. 10.1161/01.CIR.98.21.2227.PubMed Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, Isea JE, Romero G: Metabolic modulation of acute myocardial infarction. The ECLA (estudios cardiologicos latinoamerica) collaborative group. Circulation. 1998, 98: 2227-2234. 10.1161/01.CIR.98.21.2227.PubMed

go back to reference Di MS, Boldrini B, Conti U, Marcucci G, Morgantini E, Ferrannini C, Natali A: Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia. Clin Sci (Lond). 2010, 119: 37-44. 10.1042/CS20090438. Di MS, Boldrini B, Conti U, Marcucci G, Morgantini E, Ferrannini C, Natali A: Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia. Clin Sci (Lond). 2010, 119: 37-44. 10.1042/CS20090438.

go back to reference Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H: Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group. Diabetes insulin-glucose in acute myocardial infarction. Eur Heart J. 1996, 17: 1337-1344. 10.1093/oxfordjournals.eurheartj.a015067.PubMed Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H: Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group. Diabetes insulin-glucose in acute myocardial infarction. Eur Heart J. 1996, 17: 1337-1344. 10.1093/oxfordjournals.eurheartj.a015067.PubMed

go back to reference Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS: Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther. 2000, 14: 615-623. 10.1023/A:1007802630604.PubMed Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS: Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther. 2000, 14: 615-623. 10.1023/A:1007802630604.PubMed

go back to reference Ceremuzynski L, Budaj A, Czepiel A, Burzykowski T, Achremczyk P, Smielak-Korombel W, Maciejewicz J, Dziubinska J, Nartowicz E, Kawka-Urbanek T, Piotrowski W, Hanzlik J, Cieslinski A, Kawecka-Jaszcz K, Gessek J, Wrabec K: Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999, 13: 191-200. 10.1023/A:1007787924085.PubMed Ceremuzynski L, Budaj A, Czepiel A, Burzykowski T, Achremczyk P, Smielak-Korombel W, Maciejewicz J, Dziubinska J, Nartowicz E, Kawka-Urbanek T, Piotrowski W, Hanzlik J, Cieslinski A, Kawecka-Jaszcz K, Gessek J, Wrabec K: Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial. Cardiovasc Drugs Ther. 1999, 13: 191-200. 10.1023/A:1007787924085.PubMed

go back to reference van der Horst IC, Zijlstra F, van ’t Hof CJ, Doggen AW, de Boer MJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gans RO, Bilo HJ: Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol. 2003, 42: 784-791. 10.1016/S0735-1097(03)00830-1.PubMed van der Horst IC, Zijlstra F, van ’t Hof CJ, Doggen AW, de Boer MJ, Suryapranata H, Hoorntje JC, Dambrink JH, Gans RO, Bilo HJ: Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol. 2003, 42: 784-791. 10.1016/S0735-1097(03)00830-1.PubMed

go back to reference Thomas DJ, Platt HS, Alberti KG: Insulin infusion (GIK) in the treatment of type 2 (non-insulin dependent) diabetes during the perioperative period. Br J Surg. 1986, 73: 898-901. 10.1002/bjs.1800731116.PubMed Thomas DJ, Platt HS, Alberti KG: Insulin infusion (GIK) in the treatment of type 2 (non-insulin dependent) diabetes during the perioperative period. Br J Surg. 1986, 73: 898-901. 10.1002/bjs.1800731116.PubMed

go back to reference Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004, 109: 1497-1502. 10.1161/01.CIR.0000121747.71054.79.PubMed Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004, 109: 1497-1502. 10.1161/01.CIR.0000121747.71054.79.PubMed

go back to reference Doenst T, Richwine RT, Bray MS, Goodwin GW, Frazier OH, Taegtmeyer H: Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg. 1999, 67: 1682-1688. 10.1016/S0003-4975(99)00326-4.PubMed Doenst T, Richwine RT, Bray MS, Goodwin GW, Frazier OH, Taegtmeyer H: Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg. 1999, 67: 1682-1688. 10.1016/S0003-4975(99)00326-4.PubMed

go back to reference Jonassen AK, Sack MN, Mjos OD, Yellon DM: Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001, 89: 1191-1198. 10.1161/hh2401.101385.PubMed Jonassen AK, Sack MN, Mjos OD, Yellon DM: Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001, 89: 1191-1198. 10.1161/hh2401.101385.PubMed

go back to reference Nygren JO, Thorell A, Soop M, Efendic S, Brismar K, Karpe F, Nair KS, Ljungqvist O: Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery. Am J Physiol. 1998, 275: E140-E148.PubMed Nygren JO, Thorell A, Soop M, Efendic S, Brismar K, Karpe F, Nair KS, Ljungqvist O: Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery. Am J Physiol. 1998, 275: E140-E148.PubMed

go back to reference Sato H, Carvalho G, Sato T, Bracco D, Codere-Maruyama T, Lattermann R, Hatzakorzian R, Matsukawa T, Schricker T: Perioperative tight glucose control with hyperinsulinemic-normoglycemic clamp technique in cardiac surgery. Nutrition. 2010, 26: 1122-1129. 10.1016/j.nut.2009.10.005.PubMed Sato H, Carvalho G, Sato T, Bracco D, Codere-Maruyama T, Lattermann R, Hatzakorzian R, Matsukawa T, Schricker T: Perioperative tight glucose control with hyperinsulinemic-normoglycemic clamp technique in cardiac surgery. Nutrition. 2010, 26: 1122-1129. 10.1016/j.nut.2009.10.005.PubMed

go back to reference Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T: Maintenance of normoglycemia during cardiac surgery. Anesth Analg. 2004, 99: 319-324. tablePubMed Carvalho G, Moore A, Qizilbash B, Lachapelle K, Schricker T: Maintenance of normoglycemia during cardiac surgery. Anesth Analg. 2004, 99: 319-324. tablePubMed

go back to reference Zuurbier CJ, Hoek FJ, Van Dijk J, Abeling NG, Meijers JC, Levels JH, De Jonge E, de Mol BA, Van Wezel HB: Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery. Br J Anaesth. 2008, 100: 442-450. 10.1093/bja/aen018.PubMed Zuurbier CJ, Hoek FJ, Van Dijk J, Abeling NG, Meijers JC, Levels JH, De Jonge E, de Mol BA, Van Wezel HB: Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery. Br J Anaesth. 2008, 100: 442-450. 10.1093/bja/aen018.PubMed

go back to reference Forlani S, Tomai F, De Paulis R, Turani F, Colella DF, Nardi P, De Notaris S, Moscarelli M, Magliano G, Crea F, Chiariello L: Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery. J Cardiovasc Surg (Torino). 2004, 45: 117-122. Forlani S, Tomai F, De Paulis R, Turani F, Colella DF, Nardi P, De Notaris S, Moscarelli M, Magliano G, Crea F, Chiariello L: Preoperative shift from glibenclamide to insulin is cardioprotective in diabetic patients undergoing coronary artery bypass surgery. J Cardiovasc Surg (Torino). 2004, 45: 117-122.

go back to reference Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C: Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J. 2002, 16: 1027-1040. 10.1096/fj.01-0793com.PubMed Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C: Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J. 2002, 16: 1027-1040. 10.1096/fj.01-0793com.PubMed

go back to reference Yue TL, Bao W, Jucker BM, Gu JL, Romanic AM, Brown PJ, Cui J, Thudium DT, Boyce R, Burns-Kurtis CL, Mirabile RC, Aravindhan K, Ohlstein EH: Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury. Circulation. 2003, 108: 2393-2399. 10.1161/01.CIR.0000093187.42015.6C.PubMed Yue TL, Bao W, Jucker BM, Gu JL, Romanic AM, Brown PJ, Cui J, Thudium DT, Boyce R, Burns-Kurtis CL, Mirabile RC, Aravindhan K, Ohlstein EH: Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury. Circulation. 2003, 108: 2393-2399. 10.1161/01.CIR.0000093187.42015.6C.PubMed

go back to reference Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjoquist PO, Pernow J: PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol. 2009, 296: H719-H727. 10.1152/ajpheart.00394.2008.PubMed Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjoquist PO, Pernow J: PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol. 2009, 296: H719-H727. 10.1152/ajpheart.00394.2008.PubMed

go back to reference Lucchinetti E, Aguirre J, Feng J, Zhu M, Suter M, Spahn DR, Harter L, Zaugg M: Molecular evidence of late preconditioning after sevoflurane inhalation in healthy volunteers. Anesth Analg. 2007, 105: 629-640. 10.1213/01.ane.0000278159.88636.aa.PubMed Lucchinetti E, Aguirre J, Feng J, Zhu M, Suter M, Spahn DR, Harter L, Zaugg M: Molecular evidence of late preconditioning after sevoflurane inhalation in healthy volunteers. Anesth Analg. 2007, 105: 629-640. 10.1213/01.ane.0000278159.88636.aa.PubMed

go back to reference Yue TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH: In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation. 2001, 104: 2588-2594. 10.1161/hc4601.099403. Yue TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH: In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation. 2001, 104: 2588-2594. 10.1161/hc4601.099403.

go back to reference Ito H, Nakano A, Kinoshita M, Matsumori A: Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model. Lab Invest. 2003, 83: 1715-1721. 10.1097/01.LAB.0000106724.29121.DA.PubMed Ito H, Nakano A, Kinoshita M, Matsumori A: Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model. Lab Invest. 2003, 83: 1715-1721. 10.1097/01.LAB.0000106724.29121.DA.PubMed

go back to reference Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A: Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. Diabetes. 2002, 51: 1507-1514. 10.2337/diabetes.51.5.1507.PubMed Khandoudi N, Delerive P, Berrebi-Bertrand I, Buckingham RE, Staels B, Bril A: Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. Diabetes. 2002, 51: 1507-1514. 10.2337/diabetes.51.5.1507.PubMed

go back to reference Shoghi KI, Finck BN, Schechtman KB, Sharp T, Herrero P, Gropler RJ, Welch MJ: In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy. Circ Cardiovasc Imaging. 2009, 2: 373-381. 10.1161/CIRCIMAGING.108.843227.PubMedCentralPubMed Shoghi KI, Finck BN, Schechtman KB, Sharp T, Herrero P, Gropler RJ, Welch MJ: In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy. Circ Cardiovasc Imaging. 2009, 2: 373-381. 10.1161/CIRCIMAGING.108.843227.PubMedCentralPubMed

go back to reference Lotz C, Lange M, Redel A, Stumpner J, Schmidt J, Tischer-Zeitz T, Roewer N, Kehl F: Peroxisome-proliferator-activated receptor gamma mediates the second window of anaesthetic-induced preconditioning. Exp Physiol. 2011, 96: 317-324. 10.1113/expphysiol.2010.055590.PubMed Lotz C, Lange M, Redel A, Stumpner J, Schmidt J, Tischer-Zeitz T, Roewer N, Kehl F: Peroxisome-proliferator-activated receptor gamma mediates the second window of anaesthetic-induced preconditioning. Exp Physiol. 2011, 96: 317-324. 10.1113/expphysiol.2010.055590.PubMed

go back to reference Russell RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH: AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004, 114: 495-503.PubMedCentralPubMed Russell RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH: AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004, 114: 495-503.PubMedCentralPubMed

go back to reference Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ: Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes. 2008, 57: 696-705. 10.2337/db07-1098.PubMed Calvert JW, Gundewar S, Jha S, Greer JJ, Bestermann WH, Tian R, Lefer DJ: Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes. 2008, 57: 696-705. 10.2337/db07-1098.PubMed

go back to reference Yin M, van der Horst IC, van Melle JP, Qian C, van Gilst WH, Sillje HH, de Boer RA: Metformin improves cardiac function in a non-diabetic rat model of post-MI heart failure. Am J Physiol Heart Circ Physiol. 2011 Yin M, van der Horst IC, van Melle JP, Qian C, van Gilst WH, Sillje HH, de Boer RA: Metformin improves cardiac function in a non-diabetic rat model of post-MI heart failure. Am J Physiol Heart Circ Physiol. 2011

go back to reference Paiva MA, Goncalves LM, Providencia LA, Davidson SM, Yellon DM, Mocanu MM: Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction. Cardiovasc Drugs Ther. 2010, 24: 25-32. 10.1007/s10557-010-6222-3.PubMedCentralPubMed Paiva MA, Goncalves LM, Providencia LA, Davidson SM, Yellon DM, Mocanu MM: Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction. Cardiovasc Drugs Ther. 2010, 24: 25-32. 10.1007/s10557-010-6222-3.PubMedCentralPubMed

go back to reference Lavanchy N, Christe G, Cand F, Wiernsperger N, Verdetti J: Effects of chronic treatment with glibenclamide and/or metformin on the resistance to ischaemia of isolated hearts from Zucker diabetic fatty rats (ZDF/GMI-fa/fa). Br J Diabetes Vasc Dis. 2003, 3: 375-380. 10.1177/14746514030030051301. Lavanchy N, Christe G, Cand F, Wiernsperger N, Verdetti J: Effects of chronic treatment with glibenclamide and/or metformin on the resistance to ischaemia of isolated hearts from Zucker diabetic fatty rats (ZDF/GMI-fa/fa). Br J Diabetes Vasc Dis. 2003, 3: 375-380. 10.1177/14746514030030051301.

go back to reference Lamberts RR, Onderwater G, Hamdani N, Vreden MJ, Steenhuisen J, Eringa EC, Loer SA, Stienen GJ, Bouwman RA: Reactive oxygen species-induced stimulation of 5′AMP-activated protein kinase mediates sevoflurane-induced cardioprotection. Circulation. 2009, 120: S10-S15. 10.1161/CIRCULATIONAHA.108.828426.PubMed Lamberts RR, Onderwater G, Hamdani N, Vreden MJ, Steenhuisen J, Eringa EC, Loer SA, Stienen GJ, Bouwman RA: Reactive oxygen species-induced stimulation of 5′AMP-activated protein kinase mediates sevoflurane-induced cardioprotection. Circulation. 2009, 120: S10-S15. 10.1161/CIRCULATIONAHA.108.828426.PubMed

go back to reference Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM: Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes. 2005, 54: 146-151. 10.2337/diabetes.54.1.146.PubMed Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM: Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes. 2005, 54: 146-151. 10.2337/diabetes.54.1.146.PubMed

go back to reference Sonne DP, Engstrom T, Treiman M: Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia-reperfusion injury in rat heart. Regul Pept. 2008, 146: 243-249. 10.1016/j.regpep.2007.10.001.PubMed Sonne DP, Engstrom T, Treiman M: Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia-reperfusion injury in rat heart. Regul Pept. 2008, 146: 243-249. 10.1016/j.regpep.2007.10.001.PubMed

go back to reference Timmers L, Henriques JP, de Kleijn DP, Devries JH, Kemperman H, Steendijk P, Verlaan CW, Kerver M, Piek JJ, Doevendans PA, Pasterkamp G, Hoefer IE: Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol. 2009, 53: 501-510. 10.1016/j.jacc.2008.10.033.PubMed Timmers L, Henriques JP, de Kleijn DP, Devries JH, Kemperman H, Steendijk P, Verlaan CW, Kerver M, Piek JJ, Doevendans PA, Pasterkamp G, Hoefer IE: Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol. 2009, 53: 501-510. 10.1016/j.jacc.2008.10.033.PubMed

go back to reference Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ: GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes. 2009, 58: 975-983. 10.2337/db08-1193.PubMedCentralPubMed Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ: GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes. 2009, 58: 975-983. 10.2337/db08-1193.PubMedCentralPubMed

go back to reference Kristensen J, Mortensen UM, Schmidt M, Nielsen PH, Nielsen TT, Maeng M: Lack of cardioprotection from subcutaneously and preischemic administered liraglutide in a closed chest porcine ischemia reperfusion model. BMC Cardiovasc Disord. 2009, 9: 31-10.1186/1471-2261-9-31.PubMedCentralPubMed Kristensen J, Mortensen UM, Schmidt M, Nielsen PH, Nielsen TT, Maeng M: Lack of cardioprotection from subcutaneously and preischemic administered liraglutide in a closed chest porcine ischemia reperfusion model. BMC Cardiovasc Disord. 2009, 9: 31-10.1186/1471-2261-9-31.PubMedCentralPubMed

go back to reference Sauve M, Ban K, Momen MA, Zhou YQ, Henkelman RM, Husain M, Drucker DJ: Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice. Diabetes. 2010, 59: 1063-1073. 10.2337/db09-0955.PubMedCentralPubMed Sauve M, Ban K, Momen MA, Zhou YQ, Henkelman RM, Husain M, Drucker DJ: Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice. Diabetes. 2010, 59: 1063-1073. 10.2337/db09-0955.PubMedCentralPubMed

go back to reference Ravassa S, Zudaire A, Diez J: GLP-1 and cardioprotection: from bench to bedside. Cardiovasc Res. 2012, 94: 316-323. 10.1093/cvr/cvs123.PubMed Ravassa S, Zudaire A, Diez J: GLP-1 and cardioprotection: from bench to bedside. Cardiovasc Res. 2012, 94: 316-323. 10.1093/cvr/cvs123.PubMed

go back to reference Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M: Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation. 2008, 117: 2340-2350. 10.1161/CIRCULATIONAHA.107.739938.PubMed Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M: Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. Circulation. 2008, 117: 2340-2350. 10.1161/CIRCULATIONAHA.107.739938.PubMed

go back to reference Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, Shannon RP: Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J Pharmacol Exp Ther. 2006, 317: 1106-1113. 10.1124/jpet.106.100982.PubMed Zhao T, Parikh P, Bhashyam S, Bolukoglu H, Poornima I, Shen YT, Shannon RP: Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. J Pharmacol Exp Ther. 2006, 317: 1106-1113. 10.1124/jpet.106.100982.PubMed

go back to reference Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP: Chronic glucagon-like-peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneosly hypertensive, heart failure prone rat. Circ Heart Fail. 2008, 1: 153-160. 10.1161/CIRCHEARTFAILURE.108.766402.PubMedCentralPubMed Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP: Chronic glucagon-like-peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneosly hypertensive, heart failure prone rat. Circ Heart Fail. 2008, 1: 153-160. 10.1161/CIRCHEARTFAILURE.108.766402.PubMedCentralPubMed

go back to reference Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, Zhang R, Su T, Ma X, Zeng C, Wang H, Ren J, Cao F: Glucagon-Like Peptide-1 Protects Against Cardiac Microvascular Injury in Diabetes Via a cAMP/PKA/Rho-Dependent Mechanism. Diabetes. 2013, ePub ahead of print Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, Zhang R, Su T, Ma X, Zeng C, Wang H, Ren J, Cao F: Glucagon-Like Peptide-1 Protects Against Cardiac Microvascular Injury in Diabetes Via a cAMP/PKA/Rho-Dependent Mechanism. Diabetes. 2013, ePub ahead of print

go back to reference Vyas AK, Yang KC, Woo D, Tzekov A, Kovacs A, Jay PY, Hruz PW: Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy. PLoS One. 2011, 6: e17178-10.1371/journal.pone.0017178.PubMedCentralPubMed Vyas AK, Yang KC, Woo D, Tzekov A, Kovacs A, Jay PY, Hruz PW: Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy. PLoS One. 2011, 6: e17178-10.1371/journal.pone.0017178.PubMedCentralPubMed

go back to reference Gejl M, Sondergaard HM, Stecher C, Bibby BM, Moller N, Botker HE, Hansen SB, Gjedde A, Rungby J, Brock B: Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes. J Clin Endocrinol Metab. 2012, 97: E1165-E1169. 10.1210/jc.2011-3456.PubMed Gejl M, Sondergaard HM, Stecher C, Bibby BM, Moller N, Botker HE, Hansen SB, Gjedde A, Rungby J, Brock B: Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes. J Clin Endocrinol Metab. 2012, 97: E1165-E1169. 10.1210/jc.2011-3456.PubMed

go back to reference Kawano T, Tanaka K, Chi H, Eguchi S, Yamazaki F, Kitamura S, Kumagai N, Yokoyama M: Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia. Anesth Analg. 2012, 115: 62-69. 10.1213/ANE.0b013e318253cbf0.PubMed Kawano T, Tanaka K, Chi H, Eguchi S, Yamazaki F, Kitamura S, Kumagai N, Yokoyama M: Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia. Anesth Analg. 2012, 115: 62-69. 10.1213/ANE.0b013e318253cbf0.PubMed

go back to reference Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van HL, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD: Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010, 121: 586-613. 10.1161/CIRCULATIONAHA.109.192703.PubMed Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van HL, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD: Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010, 121: 586-613. 10.1161/CIRCULATIONAHA.109.192703.PubMed

go back to reference Hill JO, Dorton J, Sykes MN, DiGirolamo M: Reversal of dietary obesity is influenced by its duration and severity. Int J Obes. 1989, 13: 711-722.PubMed Hill JO, Dorton J, Sykes MN, DiGirolamo M: Reversal of dietary obesity is influenced by its duration and severity. Int J Obes. 1989, 13: 711-722.PubMed

go back to reference Bartness TJ, Polk DR, McGriff WR, Youngstrom TG, DiGirolamo M: Reversal of high-fat diet-induced obesity in female rats. Am J Physiol. 1992, 263: R790-R797.PubMed Bartness TJ, Polk DR, McGriff WR, Youngstrom TG, DiGirolamo M: Reversal of high-fat diet-induced obesity in female rats. Am J Physiol. 1992, 263: R790-R797.PubMed

go back to reference Davidoff AJ, Mason MM, Davidson MB, Carmody MW, Hintz KK, Wold LE, Podolin DA, Ren J: Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab. 2004, 286: E718-E724. 10.1152/ajpendo.00358.2003.PubMed Davidoff AJ, Mason MM, Davidson MB, Carmody MW, Hintz KK, Wold LE, Podolin DA, Ren J: Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab. 2004, 286: E718-E724. 10.1152/ajpendo.00358.2003.PubMed

go back to reference Llado I, Proenza AM, Serra F, Palou A, Pons A: Dietary-induced permanent changes in brown and white adipose tissue composition in rats. Int J Obes. 1991, 15: 415-419.PubMed Llado I, Proenza AM, Serra F, Palou A, Pons A: Dietary-induced permanent changes in brown and white adipose tissue composition in rats. Int J Obes. 1991, 15: 415-419.PubMed

go back to reference Szilvassy Z, Ferdinandy P, Szilvassy J, Nagy I, Karcsu S, Lonovics J, Dux L, Koltai M: The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. J Mol Cell Cardiol. 1995, 27: 2559-2569. 10.1006/jmcc.1995.0043.PubMed Szilvassy Z, Ferdinandy P, Szilvassy J, Nagy I, Karcsu S, Lonovics J, Dux L, Koltai M: The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. J Mol Cell Cardiol. 1995, 27: 2559-2569. 10.1006/jmcc.1995.0043.PubMed

go back to reference Shinmura K, Tamaki K, Bolli R: Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K + channels in both young and aged hearts. J Mol Cell Cardiol. 2005, 39: 285-296. 10.1016/j.yjmcc.2005.03.010.PubMed Shinmura K, Tamaki K, Bolli R: Short-term caloric restriction improves ischemic tolerance independent of opening of ATP-sensitive K + channels in both young and aged hearts. J Mol Cell Cardiol. 2005, 39: 285-296. 10.1016/j.yjmcc.2005.03.010.PubMed

go back to reference Hamdy O, Goodyear LJ, Horton ES: Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am. 2001, 30: 883-907. 10.1016/S0889-8529(05)70220-6.PubMed Hamdy O, Goodyear LJ, Horton ES: Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am. 2001, 30: 883-907. 10.1016/S0889-8529(05)70220-6.PubMed

go back to reference Veiga EC, Antonio EL, Bocalini DS, Murad N, Abreu LC, Tucci PJ, Sato MA: Prior exercise training does not prevent acute cardiac alterations after myocardial infarction in female rats. Clinics (Sao Paulo). 2011, 66: 889-893. 10.1590/S1807-59322011000500028. Veiga EC, Antonio EL, Bocalini DS, Murad N, Abreu LC, Tucci PJ, Sato MA: Prior exercise training does not prevent acute cardiac alterations after myocardial infarction in female rats. Clinics (Sao Paulo). 2011, 66: 889-893. 10.1590/S1807-59322011000500028.

go back to reference Burelle Y, Wambolt RB, Grist M, Parsons HL, Chow JC, Antler C, Bonen A, Keller A, Dunaway GA, Popov KM, Hochachka PW, Allard MF: Regular exercise is associated with a protective metabolic phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2004, 287: H1055-H1063. 10.1152/ajpheart.00925.2003.PubMed Burelle Y, Wambolt RB, Grist M, Parsons HL, Chow JC, Antler C, Bonen A, Keller A, Dunaway GA, Popov KM, Hochachka PW, Allard MF: Regular exercise is associated with a protective metabolic phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2004, 287: H1055-H1063. 10.1152/ajpheart.00925.2003.PubMed

go back to reference McElroy CL, Gissen SA, Fishbein MC: Exercise-induced reduction in myocardial infarct size after coronary artery occlusion in the rat. Circulation. 1978, 57: 958-962. 10.1161/01.CIR.57.5.958.PubMed McElroy CL, Gissen SA, Fishbein MC: Exercise-induced reduction in myocardial infarct size after coronary artery occlusion in the rat. Circulation. 1978, 57: 958-962. 10.1161/01.CIR.57.5.958.PubMed

go back to reference Freimann S, Scheinowitz M, Yekutieli D, Feinberg MS, Eldar M, Kessler-Icekson G: Prior exercise training improves the outcome of acute myocardial infarction in the rat. Heart structure, function, and gene expression. J Am Coll Cardiol. 2005, 45: 931-938. 10.1016/j.jacc.2004.11.052.PubMed Freimann S, Scheinowitz M, Yekutieli D, Feinberg MS, Eldar M, Kessler-Icekson G: Prior exercise training improves the outcome of acute myocardial infarction in the rat. Heart structure, function, and gene expression. J Am Coll Cardiol. 2005, 45: 931-938. 10.1016/j.jacc.2004.11.052.PubMed